These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 32562554)

  • 1. The role of peripheral blood eosinophil counts in COVID-19 patients.
    Xie G; Ding F; Han L; Yin D; Lu H; Zhang M
    Allergy; 2021 Feb; 76(2):471-482. PubMed ID: 32562554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Peripheral Eosinophil Counts and Eosinophil to Lymphocyte Ratio (ELR) in the Clinical Course of COVID-19 Patients: A Retrospective Study.
    Georgakopoulou VE; Garmpis N; Damaskos C; Valsami S; Dimitroulis D; Diamantis E; Farmaki P; Papageorgiou CV; Makrodimitri S; Gravvanis N; Velonias S; Sklapani P; Trakas N; Antoniou EA; Kontzoglou K; Nikolidakis L; Damaskou Z; Syllaios A; Marinos G; Vogiatzi G; Korrou GE; Kyriakos G; Quiles-Sanchez LV; Patsouras A; Lamprinos D; Stelianidi A; Savvanis S; Garmpi A
    In Vivo; 2021; 35(1):641-648. PubMed ID: 33402521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.
    Cortés-Vieyra R; Gutiérrez-Castellanos S; Álvarez-Aguilar C; Baizabal-Aguirre VM; Nuñez-Anita RE; Rocha-López AG; Gómez-García A
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection.
    Zhu Z; Cai J; Tang Q; Mo YY; Deng T; Zhang X; Xu K; Wu B; Tang H; Zhang Z
    BMC Pulm Med; 2023 May; 23(1):177. PubMed ID: 37217986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPD patients with high blood eosinophil counts exhibit a lower rate of omicron infection and milder post-infection symptoms.
    Bai X; Niu Y; Wei S; Zhu Z; Xu M; Liu H; Liu X; Wang R
    Clin Respir J; 2024 Jun; 18(6):e13790. PubMed ID: 38817043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.
    Qin C; Zhou L; Hu Z; Zhang S; Yang S; Tao Y; Xie C; Ma K; Shang K; Wang W; Tian DS
    Clin Infect Dis; 2020 Jul; 71(15):762-768. PubMed ID: 32161940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
    Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
    Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for illness severity in patients with COVID-19 pneumonia: a prospective cohort study.
    Zhang N; Zhang H; Tang Y; Zhang H; Ma A; Xu F; Sun Y; Jiang L; Shan F
    Int J Med Sci; 2021; 18(4):921-928. PubMed ID: 33456349
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience in the treatment of burn patients combined with inhalation injury during the epidemic of coronavirus disease 2019].
    Jiang NN; Wang DY; Chen L; Xie WG
    Zhonghua Shao Shang Za Zhi; 2020 Jul; 36(7):568-574. PubMed ID: 32268454
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronavirus disease 2019 and peripheral blood eosinophil counts: a retrospective study.
    Eijmael M; Janssens N; le Cessie S; van Dooren Y; Koster T; Karim F
    Infection; 2021 Dec; 49(6):1325-1329. PubMed ID: 34625911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.
    Soni M
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1():137-141. PubMed ID: 33289964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of 16 patients with fecal severe acute respiratory syndrome coronavirus 2 nucleic acid-positive.
    Zhou Y; Xiao Z; Chen D; Guan J; Zhou Z; Zhang H; Zhou H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):560-564. PubMed ID: 32879107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of 2019 novel coronavirus infection and clinical characteristics of outpatients: An epidemiological study from a fever clinic in Wuhan, China.
    Wei Y; Lu Y; Xia L; Yuan X; Li G; Li X; Liu L; Liu W; Zhou P; Wang CY; Zhang H
    J Med Virol; 2020 Nov; 92(11):2758-2767. PubMed ID: 32544281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19.
    Qu R; Ling Y; Zhang YH; Wei LY; Chen X; Li XM; Liu XY; Liu HM; Guo Z; Ren H; Wang Q
    J Med Virol; 2020 Sep; 92(9):1533-1541. PubMed ID: 32181903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Value of Eosinophil Count on COVID-19 Disease Progression and Outcomes, a Retrospective Study of Leishenshan Hospital in Wuhan, China.
    Xuan W; Jiang X; Huang L; Pan S; Chen C; Zhang X; Zhu H; Zhang S; Yu W; Peng Z; Su D
    J Intensive Care Med; 2022 Mar; 37(3):359-365. PubMed ID: 34550036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of eosinophil as a diagnostic, differential, and prognostic marker for Covid-19 during pregnancy: Case-control study from tertiary center.
    Atalay A; Sinaci S; Besimoglu B; Ozkavak O; Kaya E; Kara O; Sahin D
    J Obstet Gynaecol Res; 2023 Aug; 49(8):2063-2072. PubMed ID: 37309016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinopenia <100/μL as a marker of active COVID-19: An observational prospective study.
    Outh R; Boutin C; Gueudet P; Suzuki M; Saada M; Aumaître H
    J Microbiol Immunol Infect; 2021 Feb; 54(1):61-68. PubMed ID: 33468435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Prediction of Severe COVID-19 in Patients by a Novel Immune-Related Predictive Model.
    Sun C; Xue M; Yang M; Zhu L; Zhao Y; Lv X; Lin Y; Ma D; Shen X; Cheng Y; Xuan H; Jia X; Li T; Han L
    mSphere; 2021 Oct; 6(5):e0075221. PubMed ID: 34643417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.